EXTON, Pa.,Nov. 7 /CNW/ -- Melior Discovery, Inc.announced today that it
has signed a research collaboration with Merck & Co., Inc.to evaluate the
activity of select Merck neuroscience compounds utilizing elements of Melior's
invivo Indication Discovery platform.